[PDF] Top 20 Expresión del factor de crecimiento del endotelio vascular (VEGF) durante la regeneración hepática
Has 10000 "Expresión del factor de crecimiento del endotelio vascular (VEGF) durante la regeneración hepática" found on our website. Below are the top 20 most common "Expresión del factor de crecimiento del endotelio vascular (VEGF) durante la regeneración hepática".
The burden of neovascular age-related macular degeneration: a patient’s perspective
... The burden on caregivers was calculated based on time spent (in hours), time lost from leisure activities, or time taken off from work to assist the patient with the treat- ment of ...a patient and ... See full document
8
Stereotactic radiotherapy for wet age-related macular degeneration: current perspectives
... Abstract: Neovascular age-related macular degeneration is a leading cause of blindness in the developed ...substantial burden on patients and the health ...for ... See full document
19
Resistance to anti-VEGF therapy in neovascular age-related macular degeneration: a comprehensive review
... persistent or recurrent SRF or IRF despite previous standard anti-VEGF therapy. Compared to Forooghian et al’s study, the LAST study, and Brown et al’s trial, the conclusion of the HARBOR trial may be more persuasive ... See full document
39
Radiation therapy for neovascular age-related macular degeneration
... with neovascular (wet) age-related macular degeneration (neovascular ...considerable burden of care, and not all patients ...cause neovascular AMD, including ... See full document
15
Treatment of neovascular age-related macular degeneration: Current therapies
... With that in mind, we herein see the great advantage of a therapy tailored to address not only the specifi c characteristics of a patient’s disease (ie, minimally classic or predominantly classic lesions), but the ... See full document
6
Profile of conbercept in the treatment of neovascular age-related macular degeneration
... However, its off-label status has limited the use of bevaci- zumab, and there is concern about sterility with repacking. Conbercept (6,800 RMB [US$1,108] in People’s Republic of China) is approximately 60% the price of ... See full document
8
Combination of ranibizumab and indomethacin for neovascular age-related macular degeneration: randomized controlled trial
... Our study has a few limitations: first, we included a limited number of patients in a pilot study design. Second, the evalua- tion of adverse events was limited to eye and headache symp- toms. Third, we only assessed ... See full document
14
Circulating monocytes and B-lymphocytes in neovascular age-related macular degeneration
... The neovascular AMD group had significantly lower rela- tive amounts of monocytes compared with the control group, because among all leukocytes, only ...the neovascular AMD group, compared with ... See full document
10
Treatment of age-related macular degeneration: focus on ranibizumab
... exudative age-related macu- lar degeneration ...of neovascular AMD and across all lesion sizes when the drug is injected at monthly intervals as shown in two pivotal phase III trials (ANCHOR ... See full document
23
The effect of intravitreal bevacizumab (Avastin<sup>®</sup>) on ocular pulse amplitude in neovascular age-related macular degeneration
... 38 neovascular AMD patients were recruited, and 30 patients were included in the final analysis (18 females and 12 males; age ...and age, heart rate, systemic blood pressure, axial length, ... See full document
28
Association of rs6982567 near GDF6with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy in a Han Chinese cohort
... Bruch’ s membrane is the innermost layer of the choroid and is rich in elastin and collagen. Typical findings of PCV on ICGA include an abnormal choroidal vascular network surrounded by characteristic polyp-like ... See full document
5
Higher plasma levels of complement C3a, C4a and C5a increase the risk of subretinal fibrosis in neovascular age-related macular degeneration
... ’ s membrane and choroid of AMD eyes [27]. Stud- ies conducted in patient samples as well as in animal models of laser-induced CNV have shown that comple- ment activation may contribute to CNV development ... See full document
11
Evaluation of the effect of intravitreal ranibizumab injections in patients with neovascular age related macular degeneration on retinal nerve fiber layer thickness using optical coherence tomography
... Methods: Thirty eyes of 30 patients with nAMD were selected. All patients received three ranibizumab injections and underwent scans using the fast RNFL thickness protocol (Stratus optical coherence tomography) before ... See full document
7
Original Article COL8A1 rs13095226 polymorphism shows no association with neovascular age-related macular degeneration or polypoidal choroidal vasculopathy in Chinese subjects
... (mean age ± SD, ...(mean age ± SD, ...for age, gender, different genotypes, and various genetic models based on a logistic regression model, the associations remained insignificant (all ... See full document
60
The association between neovascular age-related macular degeneration and regulatory T cells in peripheral blood
... Twenty-one neovascular AMD cases and 12 age-matched controls without retinal pathology were ...of neovascular AMD was confirmed using fluorescein and indocyaningreen ... See full document
14
Cost-effectiveness of ranibizumab for neovascular age-related macular degeneration
... for neovascular age-related macular degeneration, which included an independent economic evaluation ...a patient who becomes blind was only one-fifth of the cost estimate derived ... See full document
135
Ranibizumab in neovascular age-related macular degeneration
... Complications from intraocular treatment may generally be classified into those related to the mode of drug delivery (ie, the intravitreal injection) or those related to the drug itself. Over a 1 year study ... See full document
35
Widening use of dexamethasone implant for the treatment of macular edema
... of macular edema related to diabetic retinopathy, branch retinal vein occlusion, central retinal vein occlusion, and non-infectious ...with macular edema have been treated by DEX implant, including ... See full document
24
Immediate effect of intravitreal injection of bevacizumab on intraocular pressure
... We included 291 eyes of 291 patients. The mean age was 75 years (ranging from 35–95 years), with 64.3% of the patients being women. One hundred seventy-one eyes were phakic, 114 were pseudophakic, and 6 were ... See full document
13
Association of treatment adherence with real-life VA outcomes in AMD, DME, and BRVO patients
... for patient- associated treatment ...and patient-associated causes of NA, as well as the inclusion of three disease entities (nAMD, DME, and BRVO), allowing comparison of NA in different clinical ... See full document
6
Related subjects